Detalhe da pesquisa
1.
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
N Engl J Med
; 378(22): 2093-2104, 2018 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29658845
2.
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
N Engl J Med
; 376(25): 2415-2426, 2017 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28636851
3.
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy.
BMC Cancer
; 17(1): 502, 2017 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28747156
4.
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.
Lancet Oncol
; 16(3): 257-65, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25704439
5.
A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report.
Front Oncol
; 13: 1102184, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37025588
6.
Corrigendum: A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: a case report.
Front Oncol
; 13: 1306238, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936611
7.
Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study.
Genes (Basel)
; 11(8)2020 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32806537
8.
Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer.
Lung Cancer
; 129: 35-40, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30797489
9.
The safety of nivolumab for the treatment of advanced non-small cell lung cancer.
Expert Opin Drug Saf
; 16(1): 101-109, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27910704
10.
Enteric-type adenocarcinoma of the lung harbouring a novel KRAS Q22K mutation with concomitant KRAS polysomy: a case report.
Ecancermedicalscience
; 9: 559, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26284123
11.
Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab.
Cancer Chemother Pharmacol
; 63(6): 1157-9, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18987856